Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > The "market" doesn't like the Roth Report..........
View:
Post by somweyungguy on Oct 09, 2015 1:34pm

The "market" doesn't like the Roth Report..........

Down to .405...we could go lower...

There must be something "unsettling" in that report, unless of course somebody is "keeping a lid on it"

: - )
Comment by higgsboson on Oct 09, 2015 1:46pm
see what I mean HT   another ignorant post    as expected by this basher/fool who cannot see that somebody is keeping a lid on it
Comment by DamnYankees on Oct 09, 2015 2:03pm
No lid here Higgy. Just no compelling reason to buy with out catalysts on the horizon. Need to get through 15 for 1 reverse and next Option gifting before catalysts arise. There could be a small run up before Late Feb but many buying opportunities ahead. remember, as the management presentation and analysts are saying " trial endpoints were not met" . Keep that in mind when you invest.
Comment by givmeabrake on Oct 09, 2015 3:34pm
Ambitious 40% DFS at one year not met 25% overall Year 1 DFS rate 35% Year 1 DFS rate in patients with papillary tumors only REMEMBER this was a study done on people who failed current BCG  treatment. 20% DFS response at 1 year IS considered relevant by Urologists - alternative is radical cystectomy!    
Comment by DryBones on Oct 09, 2015 3:53pm
You may feel based  Higgy, but the facts are otherwise.  The biggest bash came from Endo that bought our rights and set up a bound to fail trial.  All this to try to get a market for their own lousy drug. I bashed Endo and BNC then and I was right. Who got bashed the most?  Those people who needed the treatment and lost their bladders because nothiing more was available. So ...more  
Comment by higgsboson on Oct 09, 2015 4:00pm
the only reason I called you a basher is that you quoted 40 and 25 (which are true) without pointing out that 40 was self-imposed and too ambitious while 25 achieved was/is actually better than what others have done and what is on the market today
Comment by higgsboson on Oct 09, 2015 4:04pm
btw  referring to manipulation of sp  have a look and see how certain houses/traders take turns to provide down-ticks especially at the end of the day  i will not name the house that played that role today
Comment by DamnYankees on Oct 09, 2015 4:16pm
If you are correct and all they can attract to this approval stage bladder cancer treatment are penny stock manipulators and 3rd rate bashers management haven't done anything to serve the interests of shareholders have they? In the abscence of an IR effort to speak of,  all I care about is the next catalyst for cheap management options. That is what provides us the best idea of what ...more  
Comment by terr2 on Oct 09, 2015 4:18pm
That would be Mr. Anonymous.
Comment by DryBones on Oct 09, 2015 4:07pm
No, Higgy I'm prety  sure I quoted neither.
Comment by higgsboson on Oct 09, 2015 8:12pm
my mistake DY   it was sh-it-guy that referred to the 40 and 25 figures     just the same i provided additional accurate info
Comment by DryBones on Oct 09, 2015 2:05pm
Pigsbosom-  another deluded investor.  TST is long term hold.  No miracles happening here.  You have to wait it out. The claim that there are sol called bashers here does more harm than anything.
Comment by higgsboson on Oct 09, 2015 2:37pm
its not a claim db  look at the post by sh-it-guy  and you want yto tell me there are no bashers  get real  like i said they are transparent  and  if you cannot see them check your prescription
Comment by DamnYankees on Oct 09, 2015 2:53pm
Higgs you are looking to find excuses for the horrible valuation of this approval level play and trying to lay it on "bashers". Look a little further down the end of your nose and figure out who will be the real beneficiary of this disasterous valuation. Who stsnds to benefit most, with the least risk and a little more info at their fingertips. Until next time remember that "the ...more  
Comment by higgsboson on Oct 09, 2015 3:20pm
don't look now you fool  you have just become a basher quoting talking points just like in the election campaigns going on now and just like all the other bashers    actually maybe you are so sensitive because you were a basher all along  and bashers have to stand together     keep bashing pinocchio
Comment by cheetio on Oct 10, 2015 3:04pm
only thing he will see lookin down the end of his nose is the start of his footlong lapper ....right higgy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities